# Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients

> **NCT04371822** · PHASE1 · UNKNOWN · sponsor: **Kafrelsheikh University** · enrollment: 56 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** SnPP Protoporphyrin plus Sunlight exposure
- **DRUG:** SnPP Protoporphyrin plus Sunlight exposure
- **DRUG:** SnPP Protoporphyrin plus Sunlight exposure
- **DRUG:** Sulfonatoporphyrin(TPPS) plus Sunlight exposure.
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT04371822
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2020-10
- **Final completion:** 2020-11
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2020-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04371822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04371822, "Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04371822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*